A recent work using translocator protein (TSPO) PET for inflammation in MS has shown that about 60% of plaques exhibit a chronic inflammatory component, which is linked to cortical atrophy, neurodegeneration, and disability progression [106], possibly through a failure to repair. The gene discussed is TSPO; the disease is myeloid sarcoma.